Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

L Quaye; H Song; S J Ramus; A Gentry-Maharaj; E Høgdall; R A DiCioccio; V McGuire; A H Wu; D J Van Den Berg; M C Pike; E Wozniak; J A Doherty; M A Rossing; R B Ness; K B Moysich; C Høgdall; J Blaakaer; Ovarian Cancer Association Consortium; D F Easton; B A J Ponder; I J Jacobs; U Menon; A S Whittemore; S Krüger-Kjaer; C L Pearce; P D P Pharoah; S A Gayther

doi:10.1038/sj.bjc.6604947

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

L Quaye, H Song, S J Ramus, A Gentry-Maharaj, E Høgdall, R A DiCioccio, V McGuire, A H Wu, D J Van Den Berg, M C Pike, E Wozniak, J A Doherty, M A Rossing, R B Ness, K B Moysich, C Høgdall, J Blaakaer, Ovarian Cancer Association Consortium, D F Easton, B A J PonderI J Jacobs, U Menon, A S Whittemore, S Krüger-Kjaer, C L Pearce, P D P Pharoah, S A Gayther

21 Citations (Scopus)

Abstract

Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95% confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.

Original language	English
Journal	British Journal of Cancer
Volume	100
Issue number	6
Pages (from-to)	993-1001
Number of pages	8
ISSN	0007-0920
DOIs	https://doi.org/10.1038/sj.bjc.6604947
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.bjc.6604947

Cite this

Quaye, L., Song, H., Ramus, S. J., Gentry-Maharaj, A., Høgdall, E., DiCioccio, R. A., McGuire, V., Wu, A. H., Van Den Berg, D. J., Pike, M. C., Wozniak, E., Doherty, J. A., Rossing, M. A., Ness, R. B., Moysich, K. B., Høgdall, C., Blaakaer, J., Ovarian Cancer Association Consortium, Easton, D. F., ... Gayther, S. A. (2009). Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer, 100(6), 993-1001. https://doi.org/10.1038/sj.bjc.6604947

Quaye, L, Song, H, Ramus, SJ, Gentry-Maharaj, A, Høgdall, E, DiCioccio, RA, McGuire, V, Wu, AH, Van Den Berg, DJ, Pike, MC, Wozniak, E, Doherty, JA, Rossing, MA, Ness, RB, Moysich, KB, Høgdall, C, Blaakaer, J, Ovarian Cancer Association Consortium, Easton, DF, Ponder, BAJ, Jacobs, IJ, Menon, U, Whittemore, AS, Krüger-Kjaer, S, Pearce, CL, Pharoah, PDP & Gayther, SA 2009, 'Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer', British Journal of Cancer, vol. 100, no. 6, pp. 993-1001. https://doi.org/10.1038/sj.bjc.6604947

@article{5b96b990689311df928f000ea68e967b,

title = "Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer",

abstract = "Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95% confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.",

author = "L Quaye and H Song and Ramus, {S J} and A Gentry-Maharaj and E H{\o}gdall and DiCioccio, {R A} and V McGuire and Wu, {A H} and {Van Den Berg}, {D J} and Pike, {M C} and E Wozniak and Doherty, {J A} and Rossing, {M A} and Ness, {R B} and Moysich, {K B} and C H{\o}gdall and J Blaakaer and {Ovarian Cancer Association Consortium} and Easton, {D F} and Ponder, {B A J} and Jacobs, {I J} and U Menon and Whittemore, {A S} and S Kr{\"u}ger-Kjaer and Pearce, {C L} and Pharoah, {P D P} and Gayther, {S A}",

note = "Keywords: 1-Phosphatidylinositol 3-Kinase; Adult; Aged; Female; Genes, erbB-2; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Intracellular Signaling Peptides and Proteins; Middle Aged; Oncogenes; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; ras Proteins",

year = "2009",

doi = "10.1038/sj.bjc.6604947",

language = "English",

volume = "100",

pages = "993--1001",

journal = "The British journal of cancer. Supplement",

issn = "0007-0920",

publisher = "nature publishing group",

number = "6",

}

TY - JOUR

T1 - Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

AU - Quaye, L

AU - Song, H

AU - Ramus, S J

AU - Gentry-Maharaj, A

AU - Høgdall, E

AU - DiCioccio, R A

AU - McGuire, V

AU - Wu, A H

AU - Van Den Berg, D J

AU - Pike, M C

AU - Wozniak, E

AU - Doherty, J A

AU - Rossing, M A

AU - Ness, R B

AU - Moysich, K B

AU - Høgdall, C

AU - Blaakaer, J

AU - Ovarian Cancer Association Consortium

AU - Easton, D F

AU - Ponder, B A J

AU - Jacobs, I J

AU - Menon, U

AU - Whittemore, A S

AU - Krüger-Kjaer, S

AU - Pearce, C L

AU - Pharoah, P D P

AU - Gayther, S A

N1 - Keywords: 1-Phosphatidylinositol 3-Kinase; Adult; Aged; Female; Genes, erbB-2; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Intracellular Signaling Peptides and Proteins; Middle Aged; Oncogenes; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; ras Proteins

PY - 2009

Y1 - 2009

N2 - Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95% confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.

AB - Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95% confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.

U2 - 10.1038/sj.bjc.6604947

DO - 10.1038/sj.bjc.6604947

M3 - Journal article

C2 - 19240718

SN - 0007-0920

VL - 100

SP - 993

EP - 1001

JO - The British journal of cancer. Supplement

JF - The British journal of cancer. Supplement

IS - 6

ER -

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this